What is Vikor Scientific?
Vikor Scientific is a recognized leader in the field of targeted molecular diagnostics, specializing in the rapid detection of pathogens and the identification of antibiotic resistance genes. The company provides healthcare providers with accurate and timely diagnostic results, empowering informed treatment decisions for patients with complex conditions. Their comprehensive services include PharmD guidance aimed at optimizing clinical outcomes while concurrently reducing the incidence of unnecessary antibiotic prescriptions and associated treatment expenditures. Vikor Scientific serves clinicians who are actively seeking advanced diagnostic solutions to elevate the standard of patient care.
How much funding has Vikor Scientific raised?
Vikor Scientific has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Vikor Scientific
PPP
Public-Private Partnership
What's next for Vikor Scientific?
The recent major strategic investment signals a pivotal growth phase for Vikor Scientific. This capital infusion is expected to accelerate the company's expansion initiatives, potentially involving the enhancement of its diagnostic platforms, broader market penetration, and further research and development into novel detection methodologies. The company's focus on combating antibiotic resistance and improving patient outcomes positions it favorably to capitalize on increasing healthcare demands for efficient and precise diagnostic tools.
See full Vikor Scientific company page
